Jinhe Biotechnology Co Ltd
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China.
Jinhe Biotechnology Co Ltd (002688) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.088x
Based on the latest financial reports, Jinhe Biotechnology Co Ltd (002688) has a cash flow conversion efficiency ratio of 0.088x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥229.93 Million) by net assets (CN¥2.60 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jinhe Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Jinhe Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jinhe Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jinhe Biotechnology Co Ltd ranked by their cash flow conversion efficiency.
Annual Cash Flow Conversion Efficiency for Jinhe Biotechnology Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Jinhe Biotechnology Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.50 Billion | CN¥498.42 Million | 0.199x | +152.45% |
| 2023-12-31 | CN¥2.52 Billion | CN¥198.77 Million | 0.079x | +53.88% |
| 2022-12-31 | CN¥2.43 Billion | CN¥124.47 Million | 0.051x | -9.53% |
| 2021-12-31 | CN¥2.70 Billion | CN¥152.98 Million | 0.057x | -61.53% |
| 2020-12-31 | CN¥1.75 Billion | CN¥258.08 Million | 0.147x | -5.57% |
| 2019-12-31 | CN¥1.81 Billion | CN¥282.19 Million | 0.156x | +137.16% |
| 2018-12-31 | CN¥1.78 Billion | CN¥117.17 Million | 0.066x | +295.62% |
| 2017-12-31 | CN¥1.64 Billion | CN¥27.25 Million | 0.017x | -90.98% |
| 2016-12-31 | CN¥1.58 Billion | CN¥292.41 Million | 0.185x | -9.45% |
| 2015-12-31 | CN¥1.05 Billion | CN¥214.97 Million | 0.204x | +435.95% |
| 2014-12-31 | CN¥956.13 Million | CN¥-58.02 Million | -0.061x | -136.82% |
| 2013-12-31 | CN¥900.07 Million | CN¥148.32 Million | 0.165x | +60.24% |
| 2012-12-31 | CN¥863.55 Million | CN¥88.81 Million | 0.103x | -67.74% |
| 2011-12-31 | CN¥334.40 Million | CN¥106.59 Million | 0.319x | -31.19% |
| 2010-12-31 | CN¥254.83 Million | CN¥118.05 Million | 0.463x | +291.50% |
| 2009-12-31 | CN¥196.03 Million | CN¥23.20 Million | 0.118x | +80.81% |
| 2008-12-31 | CN¥177.82 Million | CN¥11.64 Million | 0.065x | -- |